Paysign, Inc. (NASDAQ:PAYS) CEO Sells $81,750.00 in Stock

Paysign, Inc. (NASDAQ:PAYSGet Free Report) CEO Mark Newcomer sold 25,000 shares of the company’s stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $3.27, for a total value of $81,750.00. Following the completion of the sale, the chief executive officer now directly owns 9,236,886 shares of the company’s stock, valued at approximately $30,204,617.22. This trade represents a 0.27 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Mark Newcomer also recently made the following trade(s):

  • On Monday, November 18th, Mark Newcomer sold 40,000 shares of Paysign stock. The stock was sold at an average price of $3.24, for a total transaction of $129,600.00.
  • On Wednesday, October 23rd, Mark Newcomer sold 36,000 shares of Paysign stock. The shares were sold at an average price of $3.66, for a total transaction of $131,760.00.
  • On Monday, October 21st, Mark Newcomer sold 22,000 shares of Paysign stock. The stock was sold at an average price of $3.75, for a total transaction of $82,500.00.
  • On Monday, September 23rd, Mark Newcomer sold 50,000 shares of Paysign stock. The stock was sold at an average price of $4.25, for a total value of $212,500.00.
  • On Thursday, September 19th, Mark Newcomer sold 1,500 shares of Paysign stock. The shares were sold at an average price of $4.50, for a total value of $6,750.00.
  • On Friday, September 13th, Mark Newcomer sold 1,500 shares of Paysign stock. The stock was sold at an average price of $4.50, for a total value of $6,750.00.

Paysign Stock Performance

Paysign stock opened at $3.46 on Friday. The stock has a fifty day moving average of $3.81 and a 200-day moving average of $4.28. The stock has a market capitalization of $185.28 million, a P/E ratio of 23.07 and a beta of 0.95. Paysign, Inc. has a 52 week low of $2.22 and a 52 week high of $5.59.

Paysign (NASDAQ:PAYSGet Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. Paysign had a return on equity of 30.64% and a net margin of 14.28%. The firm had revenue of $15.26 million for the quarter, compared to analyst estimates of $14.96 million. During the same quarter in the previous year, the company posted $0.02 EPS. On average, research analysts forecast that Paysign, Inc. will post 0.21 earnings per share for the current year.

Institutional Trading of Paysign

Several hedge funds have recently modified their holdings of the stock. SG Americas Securities LLC acquired a new position in shares of Paysign during the third quarter valued at about $43,000. Algert Global LLC purchased a new stake in Paysign during the second quarter worth about $46,000. The Manufacturers Life Insurance Company bought a new stake in shares of Paysign in the second quarter valued at $66,000. American Century Companies Inc. purchased a new stake in shares of Paysign during the 2nd quarter valued at approximately $92,000. Finally, Bard Associates Inc. purchased a new stake in Paysign during the 3rd quarter worth about $103,000. Institutional investors own 25.89% of the company’s stock.

Analyst Ratings Changes

Separately, Barrington Research restated an “outperform” rating and issued a $7.00 price target on shares of Paysign in a research note on Monday, November 4th.

Check Out Our Latest Stock Report on PAYS

About Paysign

(Get Free Report)

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.

Read More

Insider Buying and Selling by Quarter for Paysign (NASDAQ:PAYS)

Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.